These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 9676756)

  • 1. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis.
    Monjanel-Mouterde S; Lafforgue P; Blanc A; Catalin J; Aquaviva PC; Durand A
    J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total and free methotrexate pharmacokinetics in elderly patients with rheumatoid arthritis. A comparison with young patients.
    Bressolle F; Bologna C; Kinowski JM; Arcos B; Sany J; Combe B
    J Rheumatol; 1997 Oct; 24(10):1903-9. PubMed ID: 9330930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there an optimal time to administer methotrexate in the treatment of rheumatoid arthritis?
    Carpentier N; Bertin P; Marquet P; Sabot C; Bonnet C; Debord J; Lachâtre G; Trèves R
    J Rheumatol; 1998 Jul; 25(7):1270-5. PubMed ID: 9676755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of biological variables upon pharmacokinetic parameters of intramuscular methotrexate in rheumatoid arthritis.
    Debord J; Carpentier N; Sabot C; Bertin P; Marquet P; Treves R; Merle L; Lachâtre G
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):227-30. PubMed ID: 9587050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
    Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
    J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid alters methotrexate availability in patients with rheumatoid arthritis.
    Bressolle F; Kinowski JM; Morel J; Pouly B; Sany J; Combe B
    J Rheumatol; 2000 Sep; 27(9):2110-4. PubMed ID: 10990220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of methotrexate in the guinea pig.
    Schlatter J; Di Blasi-Bouvet S; Raynaud F; Cisternino S
    Cell Mol Biol (Noisy-le-grand); 1999 May; 45(3):363-8. PubMed ID: 10386793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients.
    Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
    J Rheumatol; 1993 Feb; 20(2):263-7. PubMed ID: 8474062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis.
    Gumbhir-Shah K; Cevallos WH; DeCleene SA; Korth-Bradley JM
    J Rheumatol; 1996 Jun; 23(6):984-9. PubMed ID: 8782127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of pharmacokinetic variables in a cohort of patients with rheumatoid arthritis beginning therapy with methotrexate compared with a cohort receiving the drug for a mean of 81 months.
    Kremer JM; Petrillo GF; Hamilton RA
    J Rheumatol; 1995 Jan; 22(1):41-4. PubMed ID: 7699679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy.
    Faltaos DW; Hulot JS; Urien S; Morel V; Kaloshi G; Fernandez C; Xuan kH; Leblond V; Lechat P
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):626-33. PubMed ID: 16528531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs?
    Ahern M; Booth J; Loxton A; McCarthy P; Meffin P; Kevat S
    J Rheumatol; 1988 Sep; 15(9):1356-60. PubMed ID: 3199396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with rheumatoid arthritis treated with methotrexate (MTX): concentrations of steady-state erythrocyte MTX correlate to plasma concentrations and clinical efficacy.
    Hornung N; Ellingsen T; Attermann J; Stengaard-Pedersen K; Poulsen JH
    J Rheumatol; 2008 Sep; 35(9):1709-15. PubMed ID: 18634162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of low-dose methotrexate in adult asthmatics.
    Glynn-Barnhart AM; Erzurum SC; Leff JA; Martin RJ; Cochran JE; Cott GR; Szefler SJ
    Pharmacotherapy; 1992; 12(5):383-90. PubMed ID: 1437699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis.
    Skeith KJ; Russell AS; Jamali F; Coates J; Friedman H
    J Rheumatol; 1990 Aug; 17(8):1008-10. PubMed ID: 2213774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Karim A; Tolbert DS; Hunt TL; Hubbard RC; Harper KM; Geis GS
    J Rheumatol; 1999 Dec; 26(12):2539-43. PubMed ID: 10606360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.